SpartanNash to acquire Fresh Encounter The 49-store chain with locations in Ohio, Indiana and Kentucky has been a SpartanNash independent grocer customer for 58 years. FDA approves Dong-A ST’s Stelara biosimilarImuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. Walgreens to close 1,200 stores over next three years Walgreens Boots Alliance announced approximately 1,200 store closures over the next three years, including approximately 500 closures in fiscal 2025. Sanofi in discussions to sell a controlling stake in Opella Opella is the world's third-largest company in the OTC and vitamins, minerals and supplements market. CVS Health discontinuing certain infusion services CVS Health is planning to close or sell 29 regional pharmacies in the coming months. CVS Health laying off more than 400 Aetna employees Of the total of 416 impacted positions, 93 are held by Connecticut residents. Kroger announces extension of exchange offers, consent solicitations for Albertsons Co.’s notes Kroger has extended the expiration date for the related solicitations of consents to adopt certain proposed amendments to the indentures governing the ACI Notes. Surescripts partners with TPG TPG, a global alternative asset management firm, will join the Surescripts ownership group as a majority investor. Kroger closes sale of specialty pharmacy business Kroger finalized its specialty pharmacy business sale to Elevance Health. Walgreens taps Jason Stenta as SVP, chief commercial officer In this role, Stenta will lead the company’s commercial growth strategy. First Previous 9 10 11 12 13 Next Last
